The Chemours Company Reports Fourth Quarter and Full Year 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Chemours (CC) PT Lowered to $20 at Jefferies
February 19, 2025 5:43 AM ESTJefferies analyst Laurence Alexander lowered the price target on Chemours (NYSE: CC) to $20.00 (from $21.00) while maintaining a Hold rating.
The analyst comments "Q4 EBITDA of $179 was $14m above both consensus and our estimate. 2025 EBITDA is pegged at $825-$975m (consensus... More
